Corticosteroids for sepsis: registry versus Cochrane systematic review!
A recent report from the PROGRESS registry highlighted that low dose corticosteroids are widely used in patients with sepsis around the world. In this report, corticosteroids may be associated with increased morbidity and mortality. However, these findings should be viewed with caution given that this study has several inherent flaws because of its retrospective nature and the lack of controlled use of corticosteroids. In this commentary, these findings are contrasted with those of a recent Cochrane systematic review.
Annane
Djillali
D
General Intensive Care Unit, Raymond Poincaré Hospital, University of Versailles SQY, 104 boulevard Raymond Poincaré, 92380 Garches, France. djillali.annane@rpc.aphp.fr
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D006801:Humans; D016017:Odds Ratio; D012042:Registries / Q000706:statistics & numerical data; D012189:Retrospective Studies; D018805:Sepsis / Q000188:drug therapy*
D000305:Adrenal Cortex Hormones